When Jonah Sacha is done with his work with long-a

When Jonah Sacha is done with his work with long-acting/in-vivo production of Leronlimab the number of people functionally cured will no longer fit in a post on this board. I’m surprised the HIV community isn’t all over what Cytodyn is doing and creating some buzz. Down the road a ways but from a research standpoint it would also be interesting to do some sub-analysis on these patients and look at incidence rates/disease state reductions for some of the indications implied by CCR5 related immune regulation.